billHR10270Event Thursday, September 3, 2026Analyzed

To amend title XIX of the Social Security Act to revise the IMD exclusion under Medicaid.

Bullish

Summary

HR10270 proposes revising the IMD exclusion under Medicaid, potentially expanding federal funding for inpatient mental health and substance use treatment. The bill is in early legislative stages (referred to committee) with limited bipartisan support. If enacted, it would benefit managed care organizations and behavioral health providers, but passage is uncertain and impact is low near-term.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.HR10270 is an early-stage bill to expand Medicaid coverage for inpatient mental health and substance use treatment by revising the IMD exclusion.
  • 2.If enacted, managed care organizations ($UNH, $CNC) and behavioral health providers ($ACHC) would be primary beneficiaries.
  • 3.Passage probability is low given limited bipartisan support and early legislative stage; near-term market impact is minimal.

Market Implications

The bill is too early in the legislative process to drive material market moves. Managed care and behavioral health stocks are not currently pricing in this policy change. If the bill gains momentum (e.g., committee markup, bipartisan cosponsors), investors should watch $ACHC, , $CNC, and $HCA for potential upside. No real market data is available for these tickers in the provided data, so no price levels are cited.

Full Analysis

HR10270, introduced by Rep. Goldman (D-NY) on September 3, 2026, seeks to amend the Social Security Act to revise the Institutions for Mental Diseases (IMD) exclusion under Medicaid. Currently, federal Medicaid funds generally cannot be used for inpatient psychiatric or substance use treatment for adults aged 21-64 in IMDs. This bill would remove that restriction, allowing states to claim federal matching funds for such services. The bill has been referred to the House Committee on Energy and Commerce, with five Democratic cosponsors. It is in an early stage with no committee markup or hearings scheduled.

The money trail: The bill does not authorize or appropriate specific funding; it changes the eligibility rules for federal Medicaid matching payments. If enacted, the Congressional Budget Office would estimate the cost, likely increasing federal Medicaid spending by billions over ten years as more inpatient behavioral health services become eligible for federal reimbursement. Actual spending depends on state adoption and subsequent appropriations.

Convergence: No related signals or procurement data were provided, so no convergence analysis is possible. The bill stands alone as a targeted Medicaid policy change.

Structural winners and losers: If passed, managed care organizations with large Medicaid exposure (, $CNC) would see increased premium revenue from expanded coverage, though medical costs may rise. Pure-play behavioral health hospital operators ($ACHC) would benefit directly from increased patient volume and reimbursement. General acute care hospital operators ($HCA) with behavioral health units would also see modest gains. Losers are not clearly identifiable; the bill expands coverage without offsetting cuts.

Timeline: The bill is at the start of a long legislative path. It must pass the House Energy and Commerce Committee, the full House, the Senate (likely via the Finance Committee), and be signed by the President. Given the partisan nature and early stage, passage in the 119th Congress is uncertain. No further actions are scheduled.

Intelligence Surface

Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures

Unconfirmed

No confirming evidence found yet from contracts, insider trades, or congressional activity

$$HCA▲ Bullish

What the bill does

Revision of the IMD exclusion allows federal Medicaid matching funds for inpatient behavioral health treatment for adults aged 21-64 in IMDs, expanding coverage and reimbursement.

Who must act

Hospitals and health systems that operate inpatient psychiatric facilities, including HCA Healthcare's behavioral health hospitals.

What happens

Increased patient volume and reimbursement for inpatient behavioral health services covered by Medicaid, as more patients gain access to covered treatment.

Stock impact

HCA Healthcare operates a network of acute care and behavioral health hospitals. Expanded Medicaid coverage for IMD services could increase admissions and revenue from its behavioral health facilities, though the segment is a small portion of total revenue. Impact is positive but limited by early legislative stage.

$$ACHC▲ Bullish

What the bill does

Revision of the IMD exclusion allows federal Medicaid matching funds for inpatient behavioral health treatment for adults aged 21-64 in IMDs, expanding coverage and reimbursement.

Who must act

Behavioral health hospitals and residential treatment facilities, including Acadia Healthcare's inpatient psychiatric and substance use disorder facilities.

What happens

Increased patient volume and reimbursement for inpatient behavioral health services covered by Medicaid, as more patients gain access to covered treatment.

Stock impact

Acadia Healthcare is a pure-play operator of inpatient behavioral health facilities. Expanded Medicaid coverage for IMD services directly increases addressable patient population and revenue from Medicaid patients. This is a primary revenue driver, making Acadia a significant beneficiary. Impact is positive but contingent on legislative progress.

Key Legislators

Rep. Goldman, Daniel S. [D-NY-10]

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderAug 10, 2026

Delivering Gold Standard Childhood Vaccine Recommendations for Americans

This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.

Exec OrderAug 6, 2026

Continuing to Protect the Meaning and Value of American Citizenship

This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.

Exec OrderAug 6, 2026

Ending Birth Tourism

This executive order directs the Secretaries of State and Homeland Security to prevent foreign nationals from entering the U.S. on nonimmigrant visas for the purpose of giving birth (birth tourism), including revoking visas, barring entry, and taking action against facilitators. It defines birth tourism as entry via nonimmigrant visa for childbirth and allows humanitarian or national interest exemptions.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →